• 1
    de Snoo FA, Hayward NK. Cutaneous melanoma susceptibility and progression genes. Cancer Lett 2005; 230: 15386.
  • 2
    Laud K, Marian C, Avril MF, Barrois M, Chompret A, Goldstein AM, Tucker MA, Clark PA, Peters G, Chaudru V, Demenais F, Spatz A, et al. Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma. J Med Genet 2006; 43: 3947.
  • 3
    Laud K, Kannengiesser C, Avril MF, Chompret A, Stoppa-Lyonnet D, Desjardins L, Eychene A, Demenais F, Lenoir GM, Bressac-de Paillerets B, French Hereditary Melanoma Study Group. BRAF as a melanoma susceptibility candidate gene? Cancer Res 2003; 63: 30615
  • 4
    Meyer P, Sergi C, Garbe C. Polymorphisms of the BRAF gene predispose males to malignant melanoma. J Carcinog 2003; 2: 3947.
  • 5
    Palmer JS, Duffy DL, Box NF, Aitken JF, O'Gorman LE, Green AC, Hayward NK, Martin NG, Sturm RA. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 2000; 66: 17686.
  • 6
    Box NF, Duffy DL, Chen W, Stark M, Martin NG, Sturm R, Hayward NK. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet 2001; 69: 76573.
  • 7
    van der Velden PA, Sandkuijl LA, Bergman W, Pavel S, van Mourik L, Frants RR, Gruis NA. Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J HumGenet 2001; 69: 7749.
  • 8
    Chaudru V, Laud K, Avril MF, Miniere A, Chompret A, Bressac-de Paillerets B, Demenais F. Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees. Cancer Epidemiol Biomarkers Prev 2005; 14: 238490.
  • 9
    Hayward NK. Genetics of melanoma predisposition. Oncogene 2003; 22: 305362.
  • 10
    Gillanders E, Juo SH, Holland EA, Jones M, Nancarrow D, Freas-Lutz D, Sood R, Park N, Faruque M, Markey C, Kefford RF, Palmer J, et al. Localization of a novel melanoma susceptibility locus to 1p22. Am J Hum Genet 2003; 73: 30113.
  • 11
    Walker GJ, Indsto JO, Sood R, Faruque MU, Hu P, Pollock PM, Duray P, Holland EA, Brown K, Kefford RF, Trent JM, Mann GJ, Hayward NK. Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9-Mb interval. Genes Chromosomes Cancer 2004; 41: 5664.
  • 12
    Goldstein AM, Goldin LR, Dracopoli NC, Clark WH,Jr, Tucker MA. Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi. Am J Hum Genet 1996; 58: 10506.
  • 13
    Jonsson G, Bendahl PO, Sandberg T, Kurbasic A, Staaf J, Sunde L, Cruger DG, Ingvar C, Olsson H, Borg A. Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32. J Natl Cancer Inst 2005; 97: 137782.
  • 14
    Millikan LE, Boylon JL, Hook RR, Manning PJ. Melanoma in Sinclair swine: a new animal model. J Invest Dermatol 1974; 62: 2030.
  • 15
    Müller S, Wanke R, Distl O. Inheritance of melanocytic lesions and their association with the white colour phenotype in miniature swine. J Anim Breed Genet 2001; 118: 27583.
  • 16
    Horak V, Fortyn K, Hruban V, Klaudy J. Hereditary melanoblastoma in miniature pigs and its successful therapy by devitalization technique. Cell Mol Biol (Noisy-le-grand) 1999; 45: 111929.
  • 17
    Vincent-Naulleau S, Le Chalony C, Leplat JJ, Bouet S, Bailly C, Spatz A, Vielh P, Avril MF, Tricaud Y, Gruand J, Horak V, Frelat G, et al. Clinical and histopathological characterization of cutaneous melanomas in the melanoblastoma-bearing Libechov minipig model. Pigment Cell Res 2004; 17: 2435.
  • 18
    Das Gupta TK, Ronan SG, Beattie CW, Shilkaitis A, Amoss MS,Jr. Comparative histopathology of porcine and human cutaneous melanoma. Pediatr Dermatol 1989; 6: 28999.
  • 19
    Blangero J, Tissot RG, Beattie CW, Amoss MS,Jr. Genetic determinants of cutaneous malignant melanoma in Sinclair swine. Br J Cancer 1996; 73: 66771.
  • 20
    Hruban V, Horak V, Fortyn K, Hradecky J, Klaudy J, Smith DM, Reisnerova H, Majzlik I. Inheritance of malignant melanoma in the MeLiM strain of miniature pigs. Vet Med Czech 2004; 49: 4539.
  • 21
    Geffrotin C, Crechet F, Le Roy P, Le Chalony C, Leplat JJ, Iannuccelli N, Barbosa A, Renard C, Gruand J, Milan D, Horak V, Tricaud Y, et al. Identification of five chromosomal regions involved in predisposition to melanoma by genome-wide scan in the MeLiM swine model. Int J Cancer 2004; 110: 3950.
  • 22
    Le Chalony C, Hayes H, Frelat G, Geffrotin C. Identification and mapping of swine cyclin-dependent kinase inhibitor CDKN2A and CDKN2B exon 2 sequences. Cytogenet Cell Genet 2000; 88: 2403.
  • 23
    Le Chalony C, Renard C, Vincent-Naulleau S, Crechet F, Leplat JJ, Tricaud Y, Horak V, Gruand J, Le Roy P, Frelat G, Geffrotin C. CDKN2A region polymorphism and genetic susceptibility to melanoma in the melim swine model of familial melanoma. Int J Cancer 2003; 103: 6315.
  • 24
    Iannuccelli E, Woloszyn N, Arhainx J, Gellin J, Milan D. GEMMA: A database to manage and automate microsatellite genotyping. Presented at the Proceedings of the XXVth International Conference on Animal Genetics, Tours, France, July 21–25, 1996.
  • 25
    Yerle M, Pinton P, Robic A, Alfonso A, Palvadeau Y, Delcros C, Hawken R, Alexander L, Beattie C, Schook L, Milan D, Gellin J. Construction of a whole-genome radiation hybrid panel for high-resolution gene mapping in pigs. Cytogenet Cell Genet 1998; 82: 1828.
  • 26
    Green P, Falls K, Crooks S. CRI-MAP documentation, version 2.4, March 26, 1990.
  • 27
    Wang M, Lemon WJ, Liu G, Wang Y, Iraqi FA, Malkinson AM, You M. Fine mapping and identification of candidate pulmonary adenoma susceptibility 1 genes using advanced intercross lines. Cancer Res 2003; 63: 331724.
  • 28
    Abecasis GR, Cardon LR, Cookson WOC. A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000; 66: 27992.
  • 29
    Elsen JM, Mangin B, Goffinet B, Boichard D, Le Roy P. Alternative models for QTL detection in livestock. I. General introduction. Genet Sel Evol 1999; 31: 21324.
  • 30
    Le Roy P, Elsen JM, Boichard D, Mangin B, Bidanel JP, Goffinet B. An algorithm for QTL detection in a mixture of full and half-sib families. In: The Sixth World Congress of Genetics Applied to Livestock Production, Armidale, Australia, January 11–16, 1998. Vol. 26, 25760.
  • 31
    de Koning DJ, Janss LL, Rattink AP, van Oers PA, de Vries BJ, Groenen MA, van der Poel JJ, de Groot PN, Brascamp EW, van Arendonk JA. Detection of quantitative trait loci for backfat thickness and intramuscular fat content in pigs (Sus scrofa). Genetics 1999; 152: 167990.
  • 32
    Gustafsson AC, Kijas JM, Alderborn A, Uhlen M, Andersson L, Lundeberg J. Screening and scanning of single nucleotide polymorphisms in the pig melanocortin 1 receptor gene (MC1R) by pyrosequencing. Anim Biotechnol 2001; 12: 14553.
  • 33
    Nezer C, Moreau L, Brouwers B, Coppieters W, Detilleux J, Hanset R, Karim L, Kvasz A, Leroy P, Georges M. An imprinted QTL with major effect on muscle mass and fat deposition maps to the IGF2 locus in pigs. Nat Genet 1999; 21: 1556.
  • 34
    Robic A, Faraut T, Iannuccelli N, Lahbib-Mansais Y, Cantegrel V, Alexander L, Milan D. A new contribution to the integration of human and porcine genome maps: 623 new points of homology. Cytogenet Genome Res 2003; 102: 1008.
  • 35
    Rattink AP, Jungerius BJ, Faivre M, Chardon P, Harlizius B, Groenen MAM. Improving the comparative map of SSC2p-q13 by sample sequencing of BAC clones. Anim Genet 2001; 32: 27480.
  • 36
    Demeure O, Pomp D, Milan D, Rothschild MF, Tuggle CK. Mapping of 443 porcine EST improves the comparative maps for SSC1 and SSC7 with the human genome. Anim Genet 2005; 36: 3819.
  • 37
    Yuan ZR, Wang R, Solomon J, Luo X, Sun H, Zhang L, Shi Y. Identification and characterization of survival-related gene, a novel cell survival gene controlling apoptosis and tumorigenesis. Cancer Res 2005; 65: 1071624.
  • 38
    Katoh M, Katoh M. Identification and characterization of human SNAIL3 (SNAI3) gene in silico. Int J Mol Med 2003; 11: 3838.
  • 39
    Tilquin P, Coppieters W, Elsen JM, Lantier F, Moreno C, Baret PV. Statistical power of QTL mapping methods applied to bacteria counts. Genet Res 2001; 78: 30316.
  • 40
    Apiou F, Vincent-Naulleau S, Spatz A, Vielh P, Geffrotin C, Frelat G, Dutrillaux B, Le Chalony C. Comparative genomic hybridization analysis of hereditary swine cutaneous melanoma revealed loss of the swine 13q36-49 chromosomal region in the nodular melanoma subtype. Int J Cancer 2004; 110: 2328.
  • 41
    van Noesel MM, Versteeg R. Pediatric neuroblastomas: genetic and epigenetic ‘danse macabre’. Gene 2004; 325: 115.
  • 42
    Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 2005; 436: 11722.
  • 43
    van der Velden PA, Sandkuijl LA, Bergman W, Hille ET, Frants RR, Gruis NA. A locus linked to p16 modifies melanoma risk in Dutch familial atypical multiple mole melanoma (FAMMM) syndrome families. Genome Res 1999; 9: 57580.
  • 44
    Parris CN, Harris JD, Griffin DK, Cuthbert AP, Silver AJ, Newbold RF. Functional evidence of novel tumor suppressor genes for cutaneous malignant melanoma. Cancer Res 1999; 59: 51620.
  • 45
    Pollock PM, Welch J, Hayward NK. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development. Cancer Res 2001; 61: 115461.
  • 46
    Schmid M, Malicki D, Nobori T, Rosenbach MD, Campbell K, Carson DA, Carrera CJ. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC). Oncogene 1998; 17: 266975.
  • 47
    Christopher SA, Diegelman P, Porter CW, Kruger WD. Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line. Cancer Res 2002; 62: 663944.
  • 48
    Hellerbrand C, Muhlbauer M, Wallner S, Schuierer M, Behrmann I, Bataille F, Weiss T, Scholmerich J, Bosserhoff AK. Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma. Carcinogenesis 2006; 27: 6472.
  • 49
    Matichard E, Verpillat P, Meziani R, Gerard B, Descamps V, Legroux E, Burnouf M, Bertrand G, Bouscarat F, Archimbaud A, Picard C, Ollivaud L, et al. Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet 2004; 41: e13.
  • 50
    Landi MT, Kanetsky PA, Tsang S, Gold B, Munroe D, Rebbeck T, Swoyer J, Ter-Minassian M, Hedayati M, Grossman L, Goldstein AM, Calista D, Pfeiffer RM. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst 2005; 97: 9981007.
  • 51
    Suzuki I, Cone RD, Im S, Nordlund J, Abdel-Malek ZA. Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology 1996; 137: 162733.
  • 52
    Xu X, Thornwall M, Lundin LG, Chhajlani V. Val92Met variant of the melanocyte stimulating hormone receptor gene. Nat Genet 1996; 14: 384.
  • 53
    Scott MC, Wakamatsu K, Ito S, Kadekaro AL, Kobayashi N, Groden J, Kavanagh R, Takakuwa T, Virador V, Hearing VJ, Abdel-Malek ZA. Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation. J Cell Sci 2002; 115: 234955.
  • 54
    Robbins LS, Nadeau JH, Johnson KR, Kelly MA, Roselli-Rehfuss L, Baack E, Mountjoy KG, Cone RD. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 1993; 72: 82734.
  • 55
    Kijas JM, Wales R, Tornsten A, Chardon P, Moller M, Andersson L. Melanocortin receptor 1 (MC1R) mutations and coat color in pigs. Genetics 1998; 150: 117785.
  • 56
    Busca R, Berra E, Gaggioli C, Khaled M, Bille K, Marchetti B, Thyss R, Fitsialos G, Larribère L, Berlotto C, Virolle T, Barbry P, et al. Hypoxia-inducible factor 1 α is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells. J Cell Biol 2005; 170: 4959.
  • 57
    Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R, Bavinck JN. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001; 117: 294300.
  • 58
    Newton RA, Smit SE, Barnes CC, Pedley J, Parsons PG, Sturm RA. Activation of the cAMP pathway by variant human MC1R alleles expressed in HEK and in melanoma cells. Peptides 2005; 26: 181824.
  • 59
    Schook LB, Beever JE, Rogers J, Humphray S, Archibald A, Chardon P, Milan D, Rohrer G Eversole K. Swine genome sequencing consortium (SGSC): a strategic roadmap for sequencing the pig genome. Comp Funct Genomics 2005; 6: 2515.